In 2019, Yoon et al. [57] found that AdipoQ levels were significantly associated with a decreased risk of breast cancer, colorectal cancer, and endometrial cancer, while leptin was associated with an increased risk of cancers such as endometrial cancer and kidney cancer. The gene discussed is LEP; the disease is breast carcinoma.